SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
HuMAB companies
An SI Board Since May 2000
Posts SubjectMarks Bans
1022 55 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
222Abgenix Submits IND Application to FDA for ABX-IL8 in Leading Pulmonary Disease nigel bates-9/20/2001
221Wednesday September 19, 6:01 am Eastern Time Press Release SOURCE: Epicyte Phascaram(o)uche-9/19/2001
220Better to post them - <i>About Antibody Expression in Bacteria Bacterialnigel bates-9/19/2001
219Note the phage comments. xoma.comaknahow-9/19/2001
218Parking a couple of useful antibody articles, so I remember to read them later nigel bates-9/2/2001
217LEIDEN, Netherlands, Aug. 23 /PRNewswire/ -- Crucell N.V. (Nasdaq: CRXL - news; nigel bates-8/23/2001
216Had a look at the Eos website today after the PCOP purchase. Has recently been unigel bates-8/22/2001
215MARTINSRIED and MUNICH, Germany, Aug. 20 /PRNewswire/ -- MorphoSys AG (Neuer Marnigel bates-8/20/2001
214Conference on Engineered Antibodies Accelerating Drug Discovery & Developmentnsaf-8/18/2001
213Crucell Enters Development and Commercialization Agreement with Centocor for Humnigel bates-8/16/2001
212Abgenix and Agensys Enter Technology License Collaboration to Discover and Develnigel bates-8/14/2001
211July 19 /PRNewswire/ -- GPC Biotech (Frankfurt Stock Exchange: GPC) and MorphoSynigel bates-7/19/2001
210Rick, You may be familiar with this example of wartime stress increasing the peDoc Bones-7/15/2001
209We all know that some children are born without a chance in this competitive worscaram(o)uche-7/14/2001
208Stefaan, thank you. That is very interesting. eom.keokalani'nui-7/14/2001
207>>Which way are you leaning?<< Valuable lesson or not, I have made keokalani'nui-7/14/2001
206Wilder concerning blood brain barrier If one irradiates the brain to treat thedalroi-7/14/2001
205This is a fun one for me. Here's some precursor work............ <i>scaram(o)uche-7/14/2001
204>> I had assumed x507 gummed up cross signaling between T-cells by competiscaram(o)uche-7/14/2001
203Growth Suppression of Intracranial Xenografted Glioblastomas Overexpressing Mutakeokalani'nui-7/13/2001
202<i>potentially eliminating the harmful immune responses that have been obsscaram(o)uche-7/13/2001
201Thank you for answering that in the context of a practical example. I had assumkeokalani'nui-7/13/2001
200Not a dumb question at all. Lots of us study MEDI-507. The mechanism is not descaram(o)uche-7/13/2001
199From the dumb question dept., me as Chair. Are there any Mab agonists out therekeokalani'nui-7/11/2001
198<i>I haven't had a bet on human MAb companies (technology focus) in a nigel bates-7/10/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News